Liraglutide (Saxenda) is specifically contraindicated in inflammatory bowel disease, whilst semaglutide (Wegovy) requires caution in severe gastrointestinal conditions due to overlapping side effects and potential complications
Collaboratively, a comprehensive plan will be devised to optimize your well-being through diet, exercise, nutrition, and medications that will support your individualized weight loss journey
12:e0180285
Anger and aggressiveness are complex emotions impacted by various circumstances, including environment, stress, and personal temperament
And if people are experiencing weight loss before they reach the top dose, there is no need to increase it, said Professor Drucker
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11